Transcatheter Aortic Valve Implantation: The New Challenges of Cardiac Rehabilitation.
Simona SperlonganoFrancesca RenonMaurizio Cappelli BigazziRossella SperlonganoGiovanni CimminoAntonello D'AndreaPaolo GolinoPublished in: Journal of clinical medicine (2021)
Transcatheter aortic valve implantation (TAVI) is an increasingly widespread percutaneous intervention of aortic valve replacement (AVR). The target population for TAVI is mainly composed of elderly, frail patients with severe aortic stenosis (AS), multiple comorbidities, and high perioperative mortality risk for surgical AVR (sAVR). These vulnerable patients could benefit from cardiac rehabilitation (CR) programs after percutaneous intervention. To date, no major guidelines currently recommend CR after TAVI. However, emerging scientific evidence shows that CR in patients undergoing TAVI is safe, and improves exercise tolerance and quality of life. Moreover, preliminary data prove that a CR program after TAVI has the potential to reduce mortality during follow-up, even if randomized clinical trials are needed for confirmation. The present review article provides an overview of all scientific evidence concerning the potential beneficial effects of CR after TAVI, and suggests possible fields of research to improve cardiac care after TAVI.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- ejection fraction
- aortic valve
- transcatheter aortic valve replacement
- left ventricular
- patients undergoing
- randomized controlled trial
- minimally invasive
- healthcare
- coronary artery disease
- quality improvement
- end stage renal disease
- heart failure
- type diabetes
- cardiac surgery
- palliative care
- newly diagnosed
- cardiovascular disease
- ultrasound guided
- public health
- clinical practice
- cardiovascular events
- chronic kidney disease
- patient reported outcomes
- community dwelling
- deep learning